Assyro AI

FDA Orange Book · active-ingredient family

Mepivacaine hydrochloride

Mepivacaine hydrochloride is approved as 2 brand and 14 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CARBOCAINE · NDA 012125

2

Brand (NDA)

14

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
CARBOCAINERLDEASTMAN KODAKNDA 012125Approved Prior to Jan 1, 1982
CARBOCAINERLD×3HOSPIRANDA 012250Approved Prior to Jan 1, 1982

Generic (ANDA) products (14)

ProductApplicantApplicationTEApproved
MEPIVACAINE HYDROCHLORIDEHOSPIRA INCANDA 040806Apr 28, 2008
POLOCAINEFRESENIUS KABI USAANDA 089407Dec 01, 1986
POLOCAINEFRESENIUS KABI USAANDA 089410Dec 01, 1986
POLOCAINE-MPFFRESENIUS KABI USAANDA 089406Dec 01, 1986
POLOCAINE-MPFFRESENIUS KABI USAANDA 089408Dec 01, 1986
POLOCAINE-MPFFRESENIUS KABI USAANDA 089409Dec 01, 1986
MEPIVACAINE HYDROCHLORIDEWATSON LABSANDA 088769Nov 20, 1984
MEPIVACAINE HYDROCHLORIDEWATSON LABSANDA 088770Nov 20, 1984
SCANDONEST PLAINDEPROCOANDA 088387Oct 10, 1984
POLOCAINEDENTSPLY PHARMANDA 088653Aug 21, 1984
MEPIVACAINE HYDROCHLORIDEINTL MEDICATION SYSANDA 087509Oct 05, 1982
ARESTOCAINE HYDROCHLORIDESOLVAYANDA 084777Apr 18, 1982
ISOCAINE HYDROCHLORIDESEPTODONTANDA 080925Approved Prior to Jan 1, 1982
MEPIVACAINE HYDROCHLORIDEBELMORA LLCANDA 083559Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Mepivacaine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.